[56C11-56C11];[56D5-56D5];
A set of ~800 largely isogenic deficiency stocks created by FLP-induced recombination between FRT-carrying transgenic insertions; molecularly defined deletion endpoints correspond to initial location of the progenitor insertions. Designed to fill gaps in deletion coverage and breakpoint placement; also used to replace older available deficiencies that have not been molecularly mapped.
56C11;56D5
Breakpoint based on release 3 sequence coordinate from Thibault et al., 2004, Supplementary Table 2 (FBrf0174227) or 3 (FBrf0174228), converted to release 5 coordinate.
Breakpoint from FlyBase's release 5 sequence location of progenitor insertion.
Lethal in combination with Df(2R)BSC26. Inferred to overlap with: Df(2R)BSC26.
Df(2R)BSC135 homozygous embryos do not show any obvious musculature phenotype.
Presence of P+PBac{XP5.RB3}BSC135 was verified using the PCR methods and primers described in FBrf0175003 with the substitution of the primer 5'-CCAATGCGTTTATTTCAGGTCACG-3' for the RB3' minus primer in the Hybrid PCR protocol in the Supplementary Methods.
The cytological breakpoints of Df(2R)BSC135 predicted from the genome coordinates of PBac{RB}CG30127e02673 and P{XP}d10336 are 56C11-D1;56D5.